Tetra Radar · Company Timeline
Outlook Therapeutics Inc (OTLK)
Sector: Health Care
Earlier observations
- · FDA approval. The FDA approved Lytenava to treat patients with neovascular (wet) age-related macular degeneration.
Observations from the last 30 days, with Clusters and Heat Signatures, are in the Tetra Radar Library.
Dates are event dates. Tetra Radar observes public information for research purposes. It does not provide investment advice.